Pure Global
NCT06381908

The Effects of Combined Energy and Carbohydrate Restriction on Exercise Capacity

The Effects of Combined Energy and Carbohydrate Restriction on Exercise Capacity and Health in Overweight Women
University of Aarhus·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Overweight and Obesity
Drug/Device/Intervention
Calorie-restriction with low carbohydrate
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Aarhus
Location
Aarhus C, Denmark
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Dec 15, 2024
Enrollment
40 participants
Primary outcome

Time to exhaustion,Sprint performance,Exercise tolerance,Muscle glycogen levels

Summary

The effect of calorie restriction combined with low or moderate carbohydrate availability on
 exercise capacity, metabolism and metabolic health indicators will be measured in a
 randomized parallel group design. Forty overweight (BMI 25-30) and relatively inactive women
 (20-35 of age) will be included. These will be randomized into one of two experimental groups
 both receiving a calorie-restricted diet (-1000 kcal) combined with either low carbohydrate
 availability or moderate carbohydrate availability across a 10 day period. Laboratory-based
 physical capacity tests and blood and muscle sampling will be performed before and after the
 intervention. In addition, an additional follow-up test day will be performed after
 continuing the diet for another 48 h and then standardizing the pre-testing carbohydrate
 availability before repeating the tests of physical capacity.

ICD-10 classifications
ObesityOther obesityObesity due to excess caloriesObesity, unspecifiedObesity and other hyperalimentation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06381908
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06381908 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Aarhus and is currently Recruiting. The study focuses on Overweight and Obesity. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.